Bruce F Bell

Array ( [id] => 24435 [patent_doc_number] => 07795446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)' [patent_app_type] => utility [patent_app_number] => 12/019764 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32774 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795446.pdf [firstpage_image] =>[orig_patent_app_number] => 12019764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478066 [patent_doc_number] => 20100092385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine Derivatives' [patent_app_type] => utility [patent_app_number] => 12/524019 [patent_app_country] => US [patent_app_date] => 2008-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19491 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092385.pdf [firstpage_image] =>[orig_patent_app_number] => 12524019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6595665 [patent_doc_number] => 20100048570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'THIAZOLIDINE DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/523285 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45167 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048570.pdf [firstpage_image] =>[orig_patent_app_number] => 12523285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14088 [patent_doc_number] => 07807843 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => '1-substituted-4-nitroimidazole compound and method for preparing the same' [patent_app_type] => utility [patent_app_number] => 12/007776 [patent_app_country] => US [patent_app_date] => 2008-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36033 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807843.pdf [firstpage_image] =>[orig_patent_app_number] => 12007776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4677002 [patent_doc_number] => 20080214633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Alpha-form or beta-form crystal of acetanilide derivative' [patent_app_type] => utility [patent_app_number] => 12/007653 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4551 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214633.pdf [firstpage_image] =>[orig_patent_app_number] => 12007653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4779392 [patent_doc_number] => 20080287390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Pyrazolidinol compounds' [patent_app_type] => utility [patent_app_number] => 12/007694 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5796 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287390.pdf [firstpage_image] =>[orig_patent_app_number] => 12007694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808194 [patent_doc_number] => 20080171772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => '6-SUBSTITUTED INDOLE-3-CARBOXYLIC ACID AMIDE COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ANTAGONIST BIOLOGICAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/013239 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46707 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171772.pdf [firstpage_image] =>[orig_patent_app_number] => 12013239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 24436 [patent_doc_number] => 07795447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Imidazole compounds for the treatment of neurodegenerative disorders' [patent_app_type] => utility [patent_app_number] => 11/971272 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39495 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795447.pdf [firstpage_image] =>[orig_patent_app_number] => 11971272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615259 [patent_doc_number] => 20100099662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'HYDRAZONE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/522663 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19861 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099662.pdf [firstpage_image] =>[orig_patent_app_number] => 12522663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504009 [patent_doc_number] => 20100286406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => '1,3- DIALKYLBENZIMIDAZOLE HALOGENIDES EXHIBITING REGENERATIVE, ANTI-INFLAMMATORY, AND ANTIMICROBIAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/735253 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1380 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286406.pdf [firstpage_image] =>[orig_patent_app_number] => 12735253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916344 [patent_doc_number] => 20080096945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Amorphous and Crystalline Forms of Losartan Potassium and Process For Their Preparation' [patent_app_type] => utility [patent_app_number] => 11/963269 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9585 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096945.pdf [firstpage_image] =>[orig_patent_app_number] => 11963269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765650 [patent_doc_number] => 20080176862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'New Compounds 617' [patent_app_type] => utility [patent_app_number] => 11/959561 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72609 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176862.pdf [firstpage_image] =>[orig_patent_app_number] => 11959561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 132304 [patent_doc_number] => 07700782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => 'Compounds 569' [patent_app_type] => utility [patent_app_number] => 11/959679 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46190 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700782.pdf [firstpage_image] =>[orig_patent_app_number] => 11959679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894039 [patent_doc_number] => 20080103138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/960306 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17714 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103138.pdf [firstpage_image] =>[orig_patent_app_number] => 11960306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765706 [patent_doc_number] => 20080176918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Nonsedating Alpha-2 Agonists' [patent_app_type] => utility [patent_app_number] => 11/959356 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10240 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176918.pdf [firstpage_image] =>[orig_patent_app_number] => 11959356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217301 [patent_doc_number] => 07612211 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Benzimidazole TRPV1 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/954647 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45749 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612211.pdf [firstpage_image] =>[orig_patent_app_number] => 11954647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4583939 [patent_doc_number] => 07851467 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Carbamate compounds as 5-HT4 receptor agonists' [patent_app_type] => utility [patent_app_number] => 11/999609 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18168 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851467.pdf [firstpage_image] =>[orig_patent_app_number] => 11999609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257155 [patent_doc_number] => 20100029615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'BENZIMIDAZOLE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/518970 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57239 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029615.pdf [firstpage_image] =>[orig_patent_app_number] => 12518970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753293 [patent_doc_number] => 20080161368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME' [patent_app_type] => utility [patent_app_number] => 11/950692 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22690 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161368.pdf [firstpage_image] =>[orig_patent_app_number] => 11950692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515566 [patent_doc_number] => 08039638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Inhibitors of HIV replication' [patent_app_type] => utility [patent_app_number] => 12/517310 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17569 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039638.pdf [firstpage_image] =>[orig_patent_app_number] => 12517310 [rel_patent_id] =>[rel_patent_doc_number] =>)